Heart disease claims more lives in America than any other medical problem every year, therefore keeping your heart and ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

While common risk factors like high blood pressure, high cholesterol, obesity and smoking are well-known, there are other ...

Guthrie officials said that cardiovascular diseases are the leading killer in the United States, but there are steps that ...

February is American Heart Month -- a time dedicated to raising awareness about heart disease, the leading cause of death in ...

Inside the devastating impact of heart disease on Black men in America - from healthcare barriers to community solutions, ...

A growing body of research suggests that mindfulness-based interventions may reduce stress, in turn helping to reduce ...

February is the month of love, and local cardiologists want you to show your heart some love this month with some simple, heart healthy habits.

Heart Disease Remains Leading Cause of Death as ... heart health and higher risks of preterm birth, preeclampsia and cardiovascular issues for Black and Hispanic ... Link Between Gene Duplications ...

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...